WHO ICTRP trial
Efficacy and Safety assessment of Miglitol and Metformin SR Fixed dose…
CTRI/2012/01/002336 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2012/01/002336 |
|---|---|
| Public title | Efficacy and Safety assessment of Miglitol and Metformin SR Fixed dose combination (MIGNAR MF) in patients of Type 2 Diabetes mellitus |
| Scientific title | Efficacy and Safety assessment of Miglitol and Metformin SR Fixed dose combination (MIGNAR MF) in patients of Type 2 Diabetes mellitus - NIL |
| Primary sponsor | Glenmark Pharmaceuticals Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | PMS |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: null- uncontrolled patients of Diabetes mellitus with history of high carbohydrate intake |
| Interventions | Intervention1: Mignar MF: Tablet of MIGNAR MF 25 containing Metformin SR 500 mg and Miglitol 25 mg Tablet MIGNAR MF 50 containing Metformin SR 500 mg and Miglitol 50 mg 1 tablet of MIGNAR MF taken twice daily before breakfast and dinner for… |
| Registration date | Jan 13, 2012 |
| Target size | 500 |
| Secondary IDs | GPL/MIGNAR-MF/0211/v 01; 2nd February 2011 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: